U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
Indium In-111 pentetate disodium is a radioactive diagnostic indicated for use in radionuclide cisternography. Decay of In-111 by electron capture allows for detection with a gamma camera for visualization of the brain and spinal column. Indium In 111 pentetate ( 111In-DTPA) is indicated as an imaging agent in cisternography to study the flow of cerebrospinal fluid (CSF) in the brain, to diagnose abnormalities in CSF circulation, to assess and help localize the site of CSF leakage, and to test the patency of or localize blocks in CSF shunts.

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Diagnostic
MPI INDIUM DTPA IN 111

Approved Use

Unknown

Launch Date

1982
Diagnostic
MPI INDIUM DTPA IN 111

Approved Use

Unknown

Launch Date

1982
Diagnostic
MPI INDIUM DTPA IN 111

Approved Use

Unknown

Launch Date

1982

Sample Use Guides

The maximum recommended intrathecal dose in the average patient (70 kg) is 18.5 MBq, 500 μCi. The patient dose should be measured by a suitable radioactivity calibration system immediately prior to administration.
Route of Administration: Other
Substance Class Protein
Created
by admin
on Sat Dec 16 16:07:44 GMT 2023
Edited
by admin
on Sat Dec 16 16:07:44 GMT 2023
Protein Type MONOCLONAL ANTIBODY CONJUGATE
Protein Sub Type IGG1
Sequence Origin HUMANIZED MOUSE
Sequence Type COMPLETE
Record UNII
4L3VFU7249
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
INDIUM IN-111 EPRATUZUMAB TETRAXETAN
Common Name English
EPRATUZUMAB TETRAXETAN INDIUM IN-111
Common Name English
INDIUM IN 111 LL2 IGG
Common Name English
111IN-DOTA EPRATUZUMAB
Common Name English
Code System Code Type Description
FDA UNII
4L3VFU7249
Created by admin on Sat Dec 16 16:07:44 GMT 2023 , Edited by admin on Sat Dec 16 16:07:44 GMT 2023
PRIMARY
NCI_THESAURUS
C2217
Created by admin on Sat Dec 16 16:07:44 GMT 2023 , Edited by admin on Sat Dec 16 16:07:44 GMT 2023
PRIMARY
From To
1_22 1_96
1_143 1_199
1_219 3_219
1_225 2_225
1_228 2_228
1_260 1_320
1_366 1_424
2_22 2_96
2_143 2_199
2_219 4_219
2_260 2_320
2_366 2_424
3_23 3_94
3_139 3_199
4_23 4_94
4_139 4_199
Related Record Type Details
TARGET->RADIOLIGAND
Related Record Type Details
ACTIVE MOIETY
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Molecular Formula CHEMICAL
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL